Non-Small Cell Lung Cancer Therapeutics Market 2019 Size, Share, Growth | Global Industry Research Report, 2026

SKU ID : FortuneBI- 13844544

Publishing Date : 01-Jun-2019

No. of pages : 160

PRICE
4850
6850


  • Global Non-Small Cell Lung Cancer Therapeutics market research report provides in -depth overview of an industry, including classifications, applications and industry chain structure. The Global Non-Small Cell Lung Cancer Therapeutics market evaluation is provided for global markets, including development trends, competitive landscape evaluation, and key regions development standing. Moreover, this report also helps you to understand factors driving or inhibiting the market growth along with each sub market with respect to individual growth trend and their contribution to the market.

    Non-Small Cell Lung Cancer Therapeutics market size is valued at 16,011.7 Mn US$ and will increase to 43,713.1 Mn US$ in 2026, with a CAGR of 13.4% during forecast period.

    Global Non-Small Cell Lung Cancer Therapeutics market competition by top manufacturers, with production, price, and revenue (value) and market share for each manufacturer; the TOP PLAYERS including

    Genentech (F. Hoffmann-La Roche Ltd)
    Eli Lilly and Company
    Celgene Corporation
    AstraZeneca
    Pfizer Inc.
    Sanofi
    Novartis AG
    Astellas
    Bristol Myers Squibb
    Boehringer Ingelheim Pharmaceuticals, Inc.
    Millennium Pharmaceuticals, Inc. (Takeda)
    Merck Sharp & Dohme Corp.
    Other players

    Market Segment:

    By Therapy

    Targeted Therapy
    o Bevacizumab
    o Dabrafenib/Trametinib
    o Erlotinib Hydrochloride
    o Osimertinib
    o Others

    Immunotherapy

    o Durvalumab
    o Nivolumab
    o Atezolizumab
    o Pembrolizumab
    Chemotherapy

    By Distribution Channel

    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies
    Others

    By Cancer Type

    Adenocarcinoma
    Squamous cell carcinoma
    Large cell carcinoma

    Market Segment by Application



    Key Regions split in this report: breakdown data for each region.

    Global

    In this study, the years considered to estimate the market size of Non-Small Cell Lung Cancer Therapeutics are as follows:

    Base Year: 2018
    Forecast Year: 2019- 2026

    Key Questions Answered:

    What is the market size and growth rate of the global and regional market by various segment?
    What is the market size and growth rate of the market for selective countries?
    Which region or sub-segment is expected to drive the market in the forecast period?
    What factors are estimated to drive and restrain the market growth?
    What are the key technologies and market trends shaping the market?
    What are the key opportunities in the market?
    What are the key companies operating in the market?
    Which company accounted for the highest market growth?